当前位置: 首页 > 期刊 > 《中国实用医药》 > 2010年第32期
编号:11979744
奥沙利铂联合卡培他滨治疗晚期胃癌的临床观察(2)
http://www.100md.com 2010年11月15日 《中国实用医药》 2010年第32期
     [3] Glimelius B,Ekstrom K,Hoffman K,et al.Randomized comparison between chemotherapy plus best supportive care with best supportive in advanced gastric cancer.Ann Oncol,1997,8(2):163-168.

    [4] W.Koizumi.Chemotherapy for adyanced gastric cancer:review of global and japaneese status.Gastrointestinal Cancer Research,2007,1(5):197-203.

    [5] 孙燕.内科肿瘤学.人民卫生出版社,2003:994-995.

    [6] Ohtsu A.Chemotherapy for metastatic gastric cancer:past,present,and future.J Gastroenterol, 2008,43(4):256-264.

    [7] Okines A,Chau I,Cunningham D.Capecitabine in dvanced gastric Cancer.Expert Opin Pharmacother,2007,8(16):2851-2861.

    [8] Takiuchi H,Goto M,Kawabe S,et al.Second-line chemotherapy in gasric cancer.Gan To Kagaku Ryoho,2005,32(1):19-23.

    [9] Sumpter K,Harper-Wynne C,Cunningham D,et al.Report of two protocol planned interim analyses in a randomized multicentre phase Ⅲ study comparing capecitabine with fluorouracil and oxaliplatin with cisparing in patients with advanced oesophagogastric cancer receiving ECF.Br J Cancer,2005,92(11):1976-1983., http://www.100md.com(杨亚冰 李勇猛 田 丰)
上一页1 2